Re: A review of continuous vs intermittent androgen deprivation therapy: Redefining the gold standard in the treatment of advanced prostate cancer. Myths, facts and new data on a ?perpetual dispute?
Int. braz. j. urol
; 40(2): 287-288, Mar-Apr/2014.
Article
in En
| LILACS
| ID: lil-711686
Responsible library:
BR1.1
Full text:
1
Index:
LILACS
Main subject:
Prostatic Neoplasms
/
Antineoplastic Agents, Hormonal
/
Androgen Antagonists
Limits:
Humans
/
Male
Language:
En
Journal:
Int. braz. j. urol
Journal subject:
UROLOGIA
Year:
2014
Type:
Article